Skip to Main Content
Jing Xu, M.D.,  Ph.D.

Jing Xu, M.D., Ph.D.

Titles and Appointments

Assistant Professor

School
Medical School
Department
Pathology

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

  • Education
    Medical School
    Peking Union Medical College (2003)
    Graduate School
    Johns Hopkins University (2009)
    Other Post Graduate Training
    Johns Hopkins Univeristy School of Medicine (2009)
    Residency
    Cedars-Sinai Medical Center (2018), Clinical Pathology
    Fellowship
    University of Texas Southwestern Medical Center (2020)
    Residency
    UT Southwestern Medical Center (2020), Molecular Genetics
    Residency
    UT Southwestern Medical Center (2021), Anatomic & Clinical Pathology
  • Publications

    Star Featured Publications

    PD-L1 (22C3) expression and prognostic implications in esophageal squamous cell carcinoma.
    Chi Z, Peng L, Karamchandani DM, Xu J, Ann Diagn Pathol 2025 Feb 74 152394
    Comparison of 2 T-Cell Receptor-γ Clonality Assays on Skin Biopsies Suspicious for Mycosis Fungoides.
    Miller S, Vandergriff T, Woodworth Goff H, Xu J, Oliver D, Am J Dermatopathol 2024 Sep 46 9 581-587
    INSM1 is a useful neuroendocrine marker to differentiate pancreatic serous cystadenoma from pancreatic well-differentiated neuroendocrine tumors in cytology and surgical specimens.
    Chi Z, Xu J, Karamchandani DM, Peng L, Ann Diagn Pathol 2024 Aug 71 152304
    Esophageal carcinoma with SMARCA4 mutation: a narrative review for this rare entity.
    Xu J, Chi Z, Transl Gastroenterol Hepatol 2024 9 24
    Serum D-2-hydroxyglutarate and the ratio of D-2HG/L-2HG predict IDH mutation in acute myeloid leukemia.
    Zhang C, Chu A, Boriack R, Collins R, Xu J, Oliver D, Zheng R, Rakheja D, Chen W, EJHaem 2023 Aug 4 3 723-727
    Pax8 as a useful adjunct marker to differentiate pancreatic serous cystadenoma from clear cell renal cell carcinoma in both cytologic and surgical specimens.
    Chi Z, Xu J, Karamchandani DM, Peng L, Diagn Pathol 2023 Apr 18 1 54
    GATA3 positivity is associated with poor prognosis in patients with oesophageal squamous cell carcinoma.
    Chi Z, Balani J, Gopal P, Hammer S, Xu J, Peng L, J Clin Pathol 2022 Jan
    Clinical Evaluation of the Abbott Alinity SARS-CoV-2 Spike-Specific Quantitative IgG and IgM Assays among Infected, Recovered, and Vaccinated Groups.
    Narasimhan M, Mahimainathan L, Araj E, Clark AE, Markantonis J, Green A, Xu J, SoRelle JA, Alexis C, Fankhauser K, Parikh H, Wilkinson K, Reczek A, Kopplin N, Yekkaluri S, Balani J, Thomas A, Singal AG, Sarode R, Muthukumar A, J Clin Microbiol 2021 06 59 7 e0038821
    Digital Droplet PCR for SARS-CoV-2 Resolves Borderline Cases.
    Xu J, Kirtek T, Xu Y, Zheng H, Yao H, Ostman E, Oliver D, Malter JS, Gagan JR, SoRelle JA, Am J Clin Pathol 2021 05 155 6 815-822
    "Indeterminate" UroVysion Fluorescence In Situ Hybridization Results.
    Xu J, Westfall DE, Lopategui JR, Am J Clin Pathol 2021 Mar
  • Honors & Awards
    • The Vernie A. Stembridge Faculty Teaching Award, Department of Pathology, UT Southwestern Medical Center
      (2023-2024)
    • The Arthur G. Weinberg Resident Research Award, Department of Pathology, UT Southwestern Medical Center
      (2020-2021)
  • Professional Associations/Affiliations
    • Association for Molecular Pathology
    • College of American Pathologists